Buzz Pocket

Tuesday, March 2, 2021

Intensive Care Beds Market Update - Increasing Investment Is Expected To Boost Market Growth in 2027

The emergence of COVID-19 all over the world has impacted the intensive care beds market. The increasing number of people admitting in hospitals due to ongoing corona virus crisis is predicted to be the major factor for the global market growth in 2020. Furthermore, technological advancements owing to increasing healthcare expenditure and growing R&D activities are estimated to boost the market growth after COVID-19 pandemic.

The global intensive care beds industry is predicted to witness an increase in growth rate due to the COVID-19 outbreak. According to Research Dive published report, the global intensive care beds market was likely to rise at a CAGR of 3.9% by 2027 prior to COVID-19 crisis. Now, due to the COVID-19 pandemic, the global market is expected to rise at a CAGR of 4.2% in the forecast period. This is mainly due to the increasing healthcare expenditure to enhance hospital facilities and the rise in number of hospitals & clinics all over the world. Comprehensive analysis on drivers, challenges, restraints, lucrative opportunities, and strategies implemented by market players and governments across the globe are further offered in the report.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/361

• Market Scenario During Pandemic in 2020

The projected pre COVID-19 market size for intensive care beds industry was $1,635.2 million in 2020 and is expected to witness a robust growth and reach up to $1,652.1 million due to COVID-19 pandemic. With the increasing COVID-19 cases, the demand for intensive care beds is increasing. Thus, the growing adoption of intensive care beds during the COVID-19 pandemic is predicted to be the major factor for the increase in market size in 2020. Besides, the major market players are increasingly focusing on improving production capacity and product efficiency in the pandemic, which is helping the global intensive care beds market to witness a progressive growth. For instance, in March 2020, a leading company in medical technology, Hillrom increased the manufacturing of critical care products such as hospital beds, vitals monitoring devices & accessories, and ventilators to support COVID-19 crisis.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/361

• Post-Pandemic Market Landscape till 2027

As per the report, the global intensive care beds market is expected to sustain a progressive growth even after the COVID-19 pandemic due to the increasing R&D activities and swift growth in technological advancements owing to growing healthcare expenditure. For instance, in April 2019, LINET demonstrated multi-care beds and the clinical advantages of lateralization for intensive care units (ICU) by making use of modern imaging technologies during a conference in Singapore. The leading players operating in the global market include Invacare Corporation, Hillrom, LINET, Merivaara Corp., Span America, Stryker, Medline Industries, Inc., Getinge AB, Malvestio Spa, and Stiegelmeyer GmbH & Co. KG. The report summarizes various aspects of all the prominent players functioning in the market such as financial performance, recent strategic moves & developments, product portfolio, and SWOT analysis.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Industry Dynamics: What Makes Left Atrial Appendage Closure Devices Market Outperforming Its Substitutes Despite COVID-19 Chaos?

The abrupt rise of COVID-19 pandemic has made a positive impact on the growth of the global left atrial appendage closure devices market in 2020. The increasing elderly population and rising cases of atrial fibrillation (AF) are fueling the demand for left atrial appendage closure devices during the COVID-19 crisis. Increasing product developments and technological advances by top market players are projected to unlock rewarding opportunities for the growth of the global market throughout the pandemic period.

The latest research report on the global left atrial appendage closure devices market by Research Dive divulges the impact of the COVID-19 pandemic on the current and forthcoming growth of the market. This report is a comprehensive research articulated by experts by studying top driving factors, regional market situations, latest trends and initiatives, and size & scope of the market in the course of the pandemic period.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/362

• Highlights of the Report

The sudden outburst of the COVID-19 pandemic has imposed a positive impact on the global left atrial appendage closure devices market. As per the report, the global left atrial appendage closure devices market had gathered a revenue of $466.6 million in 2019 and is expected to surpass $2,637.1 million by 2027, increasing at a CAGR of 24.0% from 2020 to 2027. The size of the market in the present situation has reached $585.2 million due to a rise in the cases of atrial fibrillation (AF) all over the world.

• Factors Impacting the Market Growth during COVID-19 Pandemic

The global left atrial appendage closure devices market is anticipated to observe noteworthy growth owing to the global increase in the cases of atrial fibrillation and growth in the geriatric population. Additionally, growing number of patients suffering from heart and stroke disorders, who are highly vulnerable to atrial fibrillation, are expected to fuel the demand for left atrial appendage closure devices; thus leading to an increased growth of the market.

• Current Face of the Market Due to COVID-19

In the course of the pandemic period, some of the foremost players in the left atrial appendage closure devices sector are implementing numerous strategies such as partnerships, collaborations, and novel product developments to grab a major position in the market. For example, in July 2020, the U.S. FDA (Food and Drug Administration) has given approval for the advanced Watchman FLX Left Atrial Appendage Closure device developed by Boston Scientific Corporation. This device is developed to minimize the possibility of stroke in NVAF (non-valvular atrial fibrillation) patients, who need a substitute for oral anticoagulation treatment by permanently sealing the left atrial appendage, the part of the heart in which stroke-causing blood clots are formed in NVAF patients.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/362

• Future Scope of the Market:

As per the report, the global left atrial appendage closure devices market is expected to undergo continuous growth post-coronavirus pandemic. New players and some of the major players including Cardia, Inc., Boston Scientific Corporation, Aegis Medical Group., AtriCure, Inc., SentreHEART, Inc., Abbott., Occlutech, Lifetech Scientific, Biosense Webster, Inc., Johnson & Johnson Services, Inc., and others are anticipated to shape the future of the global left atrial appendage closure devices industry in the next few years. The report summarizes various aspects of the prominent players functioning in the market such as financial performance, recent strategic moves & developments, product portfolio, and SWOT analysis.

Contact Us:

COVID-19 Impact: Which Are the Key Players Evolving In the Growth of Home Infusion Therapy Market?

The abrupt occurrence of COVID-19 pandemic has made a positive impact on the growth of the global home infusion therapy market in 2020. The growing geriatric population and rising cases of severe disorders are boosting the adoption of home infusion therapy during the COVID-19 crisis. Growing product launches and technological developments by leading companies is estimated to bring in rewarding opportunities for the growth of the global market during the pandemic period.

The newest research report on the global home infusion therapy market by Research Dive reveals the impact of the COVID-19 pandemic on the present and forthcoming growth of the market. This report is a meticulous research formulated by experts by reviewing regional market conditions, major driving factors, recent trends and developments, and size & scope of the market during the crisis period.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/360

• Highlights of the Report

The sudden outbreak of the COVID-19 pandemic has imposed a positive impact on the global home infusion therapy market. According to the report, the global home infusion therapy market had garnered a revenue of $20.2 billion in 2019 and is expected to exceed $49.5 billion by 2027, rising at a CAGR of 11.7% during the crisis period. The size of the market in the current scenario has reached $22.9 billion due to the increased adoption of home infusion therapy by patients during the COVID-19 turmoil.

• Factors Impacting the Market Growth during COVID-19 Pandemic

The global home infusion therapy market is expected to witness significant growth due to the global rise in the cases of acute diseases and growth in the geriatric population that needs long-term medical treatments. Furthermore, growing preference for home-based treatment by sick people, which have low immunity, to avoid getting affected by the COVID-19 infection is boosting the demand for home infusion therapy and leading to an augmented growth of the market.

• Current Market Scenario Due to COVID-19:

In the course of the pandemic period, some of the leading players in the home infusion therapy market are undertaking various strategies such as collaborations, partnerships, and new product development to withstand their market position. For example, in July 2020, Biocon biologics, an innovation led fully integrated biopharmaceutical firm, and Voluntis, a healthcare software company specialized in Patient Relationship Management (PRM), entered into a partnership to develop and offer advanced digital therapeutics based on biologics therapy for supporting diabetes patients.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/360

On the other hand, government bodies in various COVID-19 affected areas are offering support to the home infusion therapy market players to sustain their business amidst the COVID-19 disaster. For example, in October 2019, the Medicare & Medicaid Services Centers have passed a law proclaiming that all home infusion therapy overheads will get covered under the Bipartisan Budget Act of 2018.

• Future Scope of the Market:

As per the report, the global home infusion therapy market is expected to experience incessant growth post-coronavirus pandemic. New players and some of the major players including Fresenius Kabi, Baxter International, Inc., Smiths Medical., JMS Co., Ltd., ICU Medical Inc., Terumo Corporation, Eli Lilly and Company, Becton, Dickinson and Company (BD), B Braun Melsungen AG, Cosmed, and others are expected to mold the future of the global home infusion therapy market in the upcoming years.

Contact Us:

Why Dynamics of Protective Face Masks Market Is Changing Drastically? What If History Is Any Guide?

The emergence of COVID-19 across the globe has impacted the protective face masks market in a positive way. This is primarily owing to the rising cases of coronavirus coupled with the increasing need for face masks to prevent the transmission of infection. Moreover, the increasing demand for masks from healthcare institutions and the rising concern for safety are expected to be the major factors to fuel the market growth after COVID-19 pandemic.

The global protective face masks industry is likely to witness an increase in growth rate due to the outbreak of COVID-19. As per a new Research Dive published report, the global protective face masks market accounted for $1,073.1 million in 2019 and is projected to surpass $2,467.5 million by 2027. Comprehensive analysis on drivers, challenges, restraints, lucrative opportunities, and strategies implemented by market players and governments across the globe to sustain in the COVID-19 crisis are further offered in the report.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/359

• Pre Market Forecast and the Current Market Scenario

The global protective face masks industry was likely to rise at a CAGR of 10.2% by 2027 prior to COVID-19 crisis. While due to the COVID-19 pandemic, now the market is predicted to rise at a CAGR of 10.8% in the forecast period. This is mainly due to the increasing need for protective face masks due to the increasing cases of COVID-19.

The projected pre COVID-19 market size for protective face masks market was $1,176.5 million in 2020 and is expected to witness an impressive growth and reach up to $1,205.6 million due to COVID-19 pandemic. A number of companies are highly focusing on increasing the production of face masks owing to its high demand in the pandemic crisis. For instance, Arizona PPE Company has started mask production at Mesa facility.

• Prominent Players of the Industry

The major players functioning in the global protective face masks market are 3M, Reckitt Benckiser Group plc, Polison Corporation, Moldex-Metric, Inc., JSP Ltd., Intech Safety Private Limited, Alpha Solway Ltd, Mine Safety Appliances (MSA) Company, Ansell Limited, and Delta Plus Group. The report summarizes various aspects of all these key players including product portfolio, financial performance, SWOT analysis, and recent strategic moves & developments.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/359

• Post-Pandemic Market Analysis

As per the report, the global protective face masks market is predicted to sustain its progressive growth even after the pandemic. The rising concern of people related to health & safety and the rising demand for face masks from healthcare institutions are expected to be the significant factors projected to boost the global market growth during the forecast period. In addition, the focus of most companies on developing innovative protective masks is predicted to create enormous growth opportunities in the global market after COVID-19 pandemic.

Contact Us:

COVID-19 Impact Review: What Challenges Antidiabetics Market May See In Next 5 Years?

The impact of coronavirus pandemic on the global Antidiabetics market has proved to be quite positive. Unavailability of cure for diabetes and vulnerability of diabetic patients to COVID-19 has enhanced the demand for anti-diabetic drugs across the global. The key players of the market are predicted to unleash myriads of opportunities for the growth of the market in the forthcoming years by their smart strategies.

The recently published research report by Research Dive reflects on the influence of COVID-19 pandemic on the present and forthcoming growth of the global antidiabetics industry. This is a professional and all-inclusive research articulated by specialists by evaluating the major growth driving factors, important regional market situations, future opportunities and scope, and trends & developments in the market during the COVID-19 outbreak.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/339

• Highlights of the Report

A significant growth has been recorded by the global antidiabetics market in the recent years. The report reveals that the industry is estimated to garner a revenue of $148.3 million by the end of 2027, at a CAGR of 11.1% during the forecast period.

The unprecedented outbreak of coronavirus has helped the growth of the market in a fairly positive way. During the crisis, the market has collected a revenue of $70.9 million owing to the growing demand of anti-diabetic drugs.

• Factors Driving the Market Growth amid COVID-19 Pandemic

As our analysts observe, the growing cases of diabetes and non-availability of the perfect treatment for diabetes has compelled people to look for the anti-diabetics drug. Moreover, people with diabetes are more vulnerable to coronavirus. These are the factors driving the growth of global antidiabetics market.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/339

• Future Scope of the Market

According to the report, the global antidiabetics market is projected to maintain a sustainable growth post the pandemic.

New entrants and leading players including Eli Lilly and Company, Sanofi, Johnson & Johnson Services, Inc., Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Halozyme, Inc., Merck Sharp & Dohme Corp., Novartis AG, Bristol-Myers Squibb Company, Oramed and Pfizer Inc. among others.

The financial performance, product portfolio, SWOT analysis, and recent strategic moves and developments of the key players are also highlighted in the report.

Contact Us:

Is Neonatal Ventilator Market Trapped Between Growth Expectations And Uncertainty?

The novel coronavirus (COVID-19) pandemic has positively impacted the global neonatal ventilator market. According to the World Health Organization (WHO), the world population aged 40 years and above are more prone to serious respiratory problems owing to coronavirus infection. In addition, these patients are needed to be treated with ventilator to overcome respiratory problems owing to which infection can be cured and treated. Thus, soon after the COVID-19 outbreak, many manufacturers all across the globe are entering into joint agreements to produce a large number of ventilators. Moreover, the government of various countries are taking initiatives to support the business during this pandemic situation. During this unprecedented situation, we at Research Dive are helping our clients in understand the impact of COVID-19 on the market.

Our report includes:

• Technological Impact
• Social Impact
• Investment Opportunity Analysis
• Pre- & Post-COVID Market Scenario
• Infrastructure Analysis
• Supply Side & Demand Side Impact

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/197

A new report by Research Dive states that the global neonatal ventilator market is set to grow at a CAGR of 7.1% and is projected to garner a revenue of $495.3 billion during the period of forecast from 2019 to 2026. The global market is segmented on the basis of product type, mode of ventilation, mobility type, technology, end user, and region. The report delivers in-depth insights on opportunities, vital segments, restraints, drivers, and prominent players of the global market. Our analysts stated that the growing prevalence of smoking, an increase in aged population, growing attentiveness related to technological development, and improvement in healthcare centers are the significant factors boosting the growth of global neonatal ventilator market. Conversely, high costs associated with neonatal ventilator system is expected to hamper the market growth during the forecast period. Moreover, growing prevalence of respiratory and neurological diseases and rising healthcare expenditure are likely to create enormous growth opportunities in the global industry in the coming years.

• Non-Invasive Ventilation Segment to Subjugate the Industry

On the basis of product type, the global market for neonatal ventilator is segmented into non-invasive and invasive ventilation. The non-invasive ventilation subjugated the overall market in 2018 and is expected to reach up to $163.5 billion during the forecast period. The dominance of this segment is attributed to growing adoption of non-invasive ventilators as it provides benefits such as increased tolerance, no requirement of skilled employee to operate, availability outside of ICU, convenient to use, and reduced cost.

• Combined Mode of Ventilation to Grow Exponentially

Depending on the mode of ventilation, the global industry is segmented into volume mode, combined mode, pressure mode, and others. The combined mode of ventilation segment is anticipated to rise at a CAGR of 7.7% and projected to garner $93.3 billion revenue during the period of forecast. This growth is mainly owing to increased versatility, auto PEEP, safe usage, reduced time for mechanical ventilation, decreased need of human manipulation, and prevention from causing Tachypnea.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/197

• High Frequency Ventilator to Expand at Fastest Rate

Based on the technology, the neonatal ventilator market is segmented into mechanical ventilator, hybrid ventilator, volume targeted ventilator, and high frequency ventilator. Of these, the high frequency ventilator segment is estimated witness the fastest growth with 7.9% CAGR and is expected to surpass $147.3 billion by 2026. Decreased frequency and increased oxygenation, fresh gas flow, and amplitude are expected to boost the need for high frequency ventilator and thereby propel the segmental market growth in the coming future.

• Portable/Transportable Ventilator Segment to Witness Considerable Growth

On the basis of mobility type, the global market for neonatal ventilator market is segmented into portable/transportable ventilators and intensive care ventilators. The portable/transportable ventilators segment is expected to generate $181.3 billion and grow at a CAGR of 7.7% during the forecast period. On the other hand, the intensive care ventilator are extensively used due to its beneficial factors such as advanced installation of caps, leak compensation, and proximal flow sensor that rises the precision of measurement.

• Clinical Segment to be Most Lucrative

Based on the end use, the global neonatal ventilator industry is segmented into ambulatory surgical centers, clinics, hospitals, and others. The clinics segment accounted for $34.6 billion in 2018 and is estimated to rise at a CAGR of 8.1% during the period of forecast. This segment is projected to garner a revenue of $64.1 billion by 2026 owing to growing prevalence of respiratory and neurological diseases.

• Major Market Players

Some of the key players functioning in the global neonatal ventilator market include Becton, Philips Healthcare, ResMed, Drager, Fisher & Paykel, Hamilton Medical Devices, Allied Healthcare Products, Air Liquide Medical Devices, Smiths Medical, and Getinge AB.

Contact Us:

COVID-19 Outbreak: How Organ Care System Market For Lungs Will Shape Having Biggies with Strong Fundamentals?

The spread of the COVID-19 pandemic has brought a positive impact on the global organ care system for the lungs industry. Lung transplantation is still witnessing newer heights in the global market. Key players are highlighting mainly on the newer and innovative business strategies to strengthen the footprint in the market during and post-pandemic period.

The recently published research report by Research Dive reflects on the influence of COVID-19 pandemic on the present and forthcoming growth of the global organ care system for lungs industry. This is professional and all-inclusive research articulated by specialists by evaluating the major growth driving factors, important regional market situations, future opportunities and scope, and trends & developments in the market during the COVID-19 outbreak.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/341

• Highlights of the Report:

The market is anticipated to perceive growth owing to the mounting demand for increasing adoption of organ care system for lungs in the healthcare industry due to enhanced security for lung transplants during the course of the pandemic.

Significant growth has been recorded by the global organ care system for lungs market in recent years. The report reveals that the global organ care system for the lungs industry is estimated to garner a revenue of $6,577.5 million by the end of 2026, at a CAGR of 21.8% during the forecast period. The unprecedented outbreak of coronavirus has helped the growth of the market in a fairly positive way. During the crisis, the market has collected a revenue of $2,065.6 million in 2020, crossing the pre-COVID market estimations of $1,960.7 million owing to the importance of organ care against lung failure.

• Factors Driving the Market Growth amid COVID-19 Pandemic:

As per the estimation of our analyst, the rising adoption of the organ care system for the lungs system by patients with lung failure is attributing to the growth of the global organ care system for lungs industry during this hard time. The latest report published by Research Dive on the global organ care system for lungs market reveals the impact of COVID-19 pandemic on market growth. Before the rise of the pandemic, the market was expected to grow at a CAGR of 19% from 2020 to 2026. However, the sudden outburst of the COVID-19 pandemic has fueled market growth. Market experts have estimated that the market will grow at a growth rate of 21.8%, post-COVID-19 upheaval.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/341

• Current COVID-19 Impacted Scenario of the Market:

According to the report, the global organ care system for lungs market is projected to maintain a sustainable growth post the pandemic. Some of the significant organizations are mainly focusing on R&D and product launching to stay safe for the post-pandemic impact of the COVID-19. For instance, new clinical research has shown that one-third of ventilated patients have decreased deaths by new drug dexamethasone, which suppresses the immune system worldwide. The leading players of the market are focused on developing new, innovative strategies to sustain market growth.

• Future Scope of the Market:

The system of organ care aims to protect the donor organ and reduces the time for the immediate donation. These devices will monitor for the organ needed and keep it available for transplantation if and when necessary. In order to develop increased security during transplantations, scientists continue to make significant improvements to the healthcare industry. That has led to the expansion of the market for lungs in organ care systems over the last few years.

The leading players and new entrants are expected to bring in some newer innovative advances and rewarding opportunities for the market in upcoming years. The report offers the following information of the major players in the market: business overview – financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.

Contact Us:

The COVID-19 Fallout: Medical Pendant Market in 2020 - What Does the Year Ahead Hold?

The COVID-19 pandemic has impacted the global medical pendant market in a positive way. The reason attributing to the growth of the market is the surge in the medical engagement of COVID-19 patients and increasing demand of smart and effective patient care 24/7. The leading players of the market are focusing on developing strategies to sustain the market growth in the post-pandemic market.

The latest research report on the global medical pendant market by Research Dive reflects the influence of COVID-19 pandemic on the present and forthcoming growth of the global market. This report is a professional and comprehensive research formulated by specialists by evaluating top driving factors, major regional market situations, opportunities & future scope, and trends & developments in the market during the COVID-19 catastrophe.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/358

• Highlights of the Report

– As per a pre-COVID analysis, the market was expected to garner a CAGR of 7.3% during the forecast period.
– The real-time CAGR of the market is 8.1% according to the latest report for the forecast period.
– The market was estimated to reach a revenue of $ 439.2 million in 2020 as per the pre-pandemic analysis.
– The real-time global market has garnered a revenue of $450.5 million.

• Factors Attributing to the Growth of the Market

As per our analysts, rapidly growing demand for medical pendants along with hike in government investments to improve hospital amenities are fueling the market growth. Apart from that, the growing numbers of COVID-19 patients in hospitals and the need for undivided attention and care of these patients have increased the demand for medical pendants.

• Impact of COVID-19 of the Market and Current Scenario

The leading players of the market are focused on developing new, innovative strategies to sustain the market growth. For example, in May 2019, European investment bank (EIB) has lend about $129 million to Drager, a leading company in medical and safety technology, for R&D investments to improve medical technology development.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/358

• Future Scope of the Market

According to the report, the global medical pendant market is projected to maintain a sustainable growth post the pandemic. New entrants and leading players are expected to bring in some newer innovative advances and rewarding opportunities for the market in next few years. The report also summarizes other important aspects of the key players including financial performance, product portfolio, SWOT analysis, and recent strategic moves and developments.

Contact Us:

Corona Impact: Is Pneumonia Therapeutics Market will Propel with its Advanced Approaches in 2020

The coronavirus outbreak has impacted the global pneumonia therapeutics market in a positive way. The main reason behind this growth is the non-availability of treatment for COVID-19. The leading players of the market are focusing on developing strategies to sustain the market growth in the post-pandemic market.

The latest research report on the global pneumonia therapeutics market by Research Dive reflects the influence of COVID-19 pandemic on the present and forthcoming growth of the global market. This report is a professional and comprehensive research formulated by specialists by evaluating top driving factors, major regional market situations, opportunities & future scope, and trends & developments in the market during the COVID-19 catastrophe.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/357

• Highlights of the Report

– As per the previous report, the global pneumonia therapeutic market was expected to grow at a CAGR of 7.8% during the forecast period.
– The real-time CAGR has been recorded at 8.2% in a new analysis.
– The market was estimated to reach $1,783.1 million in 2020 as per the pre-pandemic analysis.
– The real-time (2020) market size has reached a revenue of $1,817.1 million.

• Factors Accelerating the Growth of the Market

The primary factor behind the growth of the global pneumonia therapeutics market is obviously the increasing transmission of the highly infectious and fatal virus. Pneumonia being the most prevalent symptom of COVID-19, the demand for pneumonia therapeutics has been increased.

• Current COVID-19 Impacted Scenario of the Market:

The leading players of the market are focused on developing new, innovative strategies to sustain the market growth. For instance, BioAegis therapeutics has recently received approval to proceed with phase 2 trial of its gelsolin COVID-19 Treatment. Gelsolin is a key component of the body’s immune system. BioAegis is in a unique position to deliver therapeutics that have the potential to disrupt the course of the cytokine storm created by COVID-19.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/357

• Future Scope of the Market:

According to the report, the global pneumonia therapeutics market is projected to maintain a sustainable growth post the pandemic. New entrants and leading players are expected to bring in some newer innovative advances and rewarding opportunities for the market in next few years. The report also summarizes other important aspects of the key players including financial performance, product portfolio, SWOT analysis, and recent strategic moves and developments.

Contact Us:

How Viscosupplementation Market Will Grow In Coming Future Despite COVID-19 Chaos?

The abrupt occurrence of the COVID-19 pandemic has imposed a positive impact on the global viscosupplementation market growth in 2020. Growing demand for viscosupplementation for treating osteoarthritis patients is boosting the growth of the market. Analysts have anticipated that market will observe incessant growth after the end of the COVID-19 disaster.

• Scenario of the Market before and after COVID-19 Pandemic:

Research Dive has added a new report on the global viscosupplementation market to its repository. The report reveals the impact of COVID-19 pandemic on the growth of the market. Before the rise of the pandemic, the market was estimated to grow at a CAGR of 10.2% from 2019 to 2026. Nevertheless, the unexpected outburst of COVID-19 pandemic has boosted the growth of the market. Market professionals have projected that the market will grow at a CAGR of 10.6% and garner $5,866.2 million, after the end of COVID-19 pandemic. This is mainly due to the rising demand for viscosupplementation due to rising cases of osteoarthritis in elderly population.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/342

• Present Scenario of the Market during COVID-19 Crisis:

Before the outbreak of the pandemic, the global viscosupplementation market was expected to hit $2,845.3 million in 2020. However, in the current circumstances, i.e. in 2020, the market size has stretched up to $2,903.3 million. The rise in the growth of the market is chiefly owing to the mounting demand for viscosupplementation for treating osteoarthritis patients. Amidst this crisis period, a significant rise in the number of osteoarthritis cases particularly in the elderly population has been witnessed. As per a publication by the United Nations (UN), by 2050, about 130 million people are likely to suffer from osteoarthritis worldwide.

• Top Players of the Market:

Some of the major players active in the viscosupplementation market are Anika Therapeutics, Inc., OrthogenRx, Bioventus., Fidia Farmaceutici S.p.A., Aptissen, ecnofarma S.A., Zimmer Biomet, TRB Chemedica International SA, Stellar Pharmaceuticals Inc., and Dr. Reddy’s Laboratories Ltd. Additionally, the report outlines the business overview including financial performance, recent strategic moves & developments, product portfolio, and SWOT analysis of all key players of the market.

As a response to COVID-19 catastrophe, market players are devising numerous business strategies, for instance, strategic agreements, technological inventions, and collaborations to survive their business. For example, OrthogenRx, Inc., a medical device manufacturing company has announced the initialization of patient programs called TriVisc Direct Purchase Program and TriVisc Patient Assistance Program, in May 2020.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/342

• Outlook of the Market Post COVID-19 Pandemic:

As per market researchers, the global viscosupplementation market is expected to continue to grow at a significant growth rate after the end of the COVID-19 crisis. This is mainly due to an upsurge in the number of sports related joint injuries owing to growing adoption of sports in upcoming years. Additionally, growing technological advances and increasing investments in the viscosupplementation technology are estimated to unlock rewarding opportunities and boost the growth of the global viscosupplementation market after the end of the COVID-19 pandemic.

Contact Us:

Monday, March 1, 2021

How COVID-19 Pandemic Will Impact on Critical Care Devices Market Growth in 2020 and Coming Future?

The coronavirus outbreak has influenced the critical care devices industry fairly and positively. Expanded usage of critical care devices is expected to fuel the demand for COVID-19 care during the forecast era. Markets are projected to provide investors with more growth prospects over time. Leading players of the market are predicted to unlock vibrant opportunities for the growth of the market in the forthcoming years by taking various initiatives.

The latest research report on the global critical care devices market by Research Dive reflects the influence of COVID-19 pandemic on the present and expected growth of the global market. This report is professional and comprehensive research formulated by specialists by evaluating top driving factors, major regional market situations, opportunities & future scope, and trends & developments in the market during the COVID-19 catastrophe.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/340

• Highlights of the Report:

The global critical care devices market has witnessed remarkable growth in the previous years. The sudden outbreak of COVID-19 has impacted the market, bringing even more chances of growth. As per the report, the global critical care devices industry is expected to register a revenue of $41.5 million by 2027, at a growth rate of 3.2% during the forthcoming years. In the current situation, the market has garnered $33.3 million in 2020, owing to the increasing demand for critical care devices across the healthcare industry.

• Factors Driving the Market Growth amid COVID-19 Pandemic:

As per our analyst estimates, the growth of the global critical care devices industry is majorly attributed to the significantly rising adoption of critical care devices system by the healthcare industry. However, high costs to obstructing the growth of the critical care devices industry.

The report discloses the real-time CAGR recorded by the market during the pandemic. According to the report, the critical care devices market has earned a CAGR of 3.2% during the last few months of the crisis, while the pre-COVID-19 estimation was only 3%. The reason behind this growth is the growing necessity of growing adoption of critical care devices in the healthcare industry owing to longer life cycles.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/340

• Current COVID-19 Impacted Scenario of the Market:

The leading players of the market are focused on developing new, innovative strategies to sustain market growth. To drive the demand during the pandemic, innovation in critical care instruments that are used in surgical procedures, and an increase in intensive care units has allowed healthcare institutions to provide better healthcare services for the patient. It is expected that a lack of skilled labor to operate such tools would hamper the demand in the forecast period.

• Future Scope of the Market:

According to the report, the global critical care devices market is projected to maintain sustainable growth post the pandemic.

New entrants and leading players including GE Healthcare, Cardinal Health, Breas Medical, Boston Scientific Corporation, Biometrix, Asahi Kasei Corporation, Airon Corporation, Air Liquide Medical Systems, Biometrix and Avanos Medical, Inc, among others are expected to bring in some newer innovative advances and rewarding opportunities for the market in next few years. The report summarizes the following aspects of all key players: business overview – financial performance, product portfolio, recent strategic moves & developments, SWOT analysis.

Contact Us: